• Home
  • Science
    • ImmunoBody®
    • Moditope®
    • Glymab®
    • Publications
  • Pipeline
  • News
  • Investors
    • Share Info
    • Financial Info
    • Documents & Presentations
    • Corporate Governance
  • Contact Us
    • Find a trial
    • Become an Investigator

Successful SCOPE outcome and iSCIB1+ selection

by chantal | Jul 22, 2025 | Inzitagene Plasmivec, SCIB1, Trinity Delta Reports

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Active Immunotherapy for a Cancer-Free Future

by chantal | Jul 22, 2025 | Immunobody, Investor Presentations, Inzitagene Plasmivec, SCIB1

Cancer vaccine data due soon; Glymab developments too

by chantal | Jul 10, 2025 | GlyMab, Inzitagene Plasmivec, Modi-1, SCIB1, Trinity Delta Reports

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Clinical & Corporate Update: Active Immunotherapy for a Cancer-Free Future

by chantal | Jun 25, 2025 | Investor Presentations

Annual Report 30th April 2025

by alex | Apr 30, 2025 | Financial Info

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Investor Update: 24 April 2025

by chantal | Apr 25, 2025 | Investor Presentations

« Older Entries
Next Entries »

Recent Posts

  • Form F-4/A (November 2026)
  • NASDAQ listing, iSCIB1+, and ModiFy updates
  • Scancell Provides Corporate and Clinical Update
  • Notice of Annual General Meeting November 2026
  • Result of General Meeting

Recent Comments

No comments to show.

Scancell is focused on developing novel immunotherapies for the treatment of cancer and was founded in 1996 based on research led by Professor Lindy Durrant at the University of Nottingham in the UK.

  • Follow
  • Follow

Science
Our Pipeline
News
Contact Us
Find a Trial
Become an Investigator

ACTIVE IMMUNOTHERAPY

ImmunoBody®
Moditope®

ANTIBODIES

GlyMab®

Investors
Company Profile
Advisors
Corporate Governance
Documents & Presentations
Share Information
Financial Information

Copyright © 2026 Scancell | Website Designed & Developed by Identity Creative | Privacy & Cookie Policy